Preoperative continuation of aspirin administration in patients undergoing major abdominal malignancy surgery
In contrast to that in a nonoperative setting, it has been shown that perioperative administration of aspirin did not decrease the rate of death or myocardial infarction but increased major bleeding risk. Since these conflicting results might be due to concurrent use of anticoagulants and a lower thrombotic risk of patients, this cohort study was carried out for patients at a high thrombotic risk without concurrent use of anticoagulants.
Medical records for patients who underwent major abdominal malignancy surgery and who were on a preoperative antiplatelet regimen were reviewed. The patients were divided into two groups according to perioperative antiplatelet management: administration of all preoperative antiplatelet agent-suspended (no aspirin) group and only aspirin administration-continued (aspirin) group. The incidence of symptomatic thromboembolic events, frequency of exogenous blood transfusion within 30 days after surgery and the amount of intraoperative bleeding were compared between the two groups.
After propensity score matching, 105 patients of each group were matched. The incidence of perioperative thromboembolic events in the no-aspirin group was significantly higher than that in the aspirin group [7/105 (6.7%) vs 0/105 (0%), 95% CI 1.44–∞, P = 0.016]. In contrast, neither the frequency of exogenous transfusion [21.0% vs 11.4%, 95% CI 0.88–4.38 P = 0.110] nor the amount of intraoperative bleeding [median (interquartile range), ml: 230 (70–500) vs 208 (50–500), P = 0.325] was different between the two groups.
Although the sample size is relatively small, our findings suggest that continuation of aspirin administration is likely to reduce the thrombotic risk but unlikely to increase the bleeding risk of patients who undergo major abdominal surgery for malignancy.
KeywordsPerioperative Aspirin Thromboembolism
- 2.Giuseppe GK, Biondi-Zoccai GGL, Lotrionte M, Agostoni p, Abbate A, Fusaro M, Burzotta F, Testa L, Sheiban I, Sangiorgi G. A systemic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50279 patients at risk for coronary artery disease. Eur Heart J. 2006;27:2667–74.CrossRefGoogle Scholar
- 6.Mantz Samama CM, Tubach F, Devereaux PJ, Collet JP, Albaladejo P, Cholley B, Nizard R, Barré J, Priou V, Poirier N, Mignon A, Schlumberger S, Longrois D, Aubrun F, Farése ME, Ravaud P, Steg PG. Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective noncardiac surgery: the multicenter randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth. 2011;107:899–910.CrossRefGoogle Scholar
- 7.Devereaux PJ, Mikobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurtz A, Villa JC, Sigamani A, Biccard BM, Meyhoff CS, Parlow JL, Guyatt G, Chan MTV, Tiboni M, Cook D, Kumar PA, Gorget P, Malaga G, Fleishmann E, Amir M, Eikelboom J, Mizera R, Torres D, Wang CY, VanHelder T, Paniagua P, Berwanger O, Srinathan S, Graham M, Pasin L, Chow C, Petti S, Chrolavicius S, Yusuf S. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370:1504–13.CrossRefGoogle Scholar
- 13.Olmos A, Govindasamy P. Propensity score: a practical introduction using R. J MultiDiscip Eval. 2015;11:68–88.Google Scholar
- 17.Steinberg BA, Kim S, Piccini JP, Fonarow GC, Lopes RD, Thomas L, Ezekowitz MD, Ansell J, Kowey P, Singer DE, Gersh B, Mahaffey KW, Hylek E, GO AS, Chang P, Peterson ED. Use and associated risks of concomitant aspirin therapy with oral anticoagulants in patients with atrial fibrillation. Insights from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry. Circulation. 2013;128:721–8.CrossRefGoogle Scholar
- 18.Graham MM, Sessler BDI, Parlow JL, Biccard BM, Guyatt G, Leslie K, Chan MTV, Meyhoff CS, Xavier D, Sigmani A, Kumar PA, Mrkobrada M, Cook DJ, Tandon V, Alvarez-Garcia J, Villar JC, Painter TW, Landoni G, Fleischmann E, Lamy A, Whitlock R, Manach YL, Aphang-Lam M, Cata JP, Gao P, Terblanche NCS, Pamana PV, Jamieson KA, Bessissow A, Mendoza GR, Ramirez S, Diemunsch PA, Yusuf S, Devereaux PJ. Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery. Ann Intern Med. 2018;68:237–44.CrossRefGoogle Scholar